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Background: The natural course and treatment strategies for asymptomatic or oligosymptomatic pancreatic
necrosis are still poorly defined. The aim of this retrospective study was to establish criteria for the need of
intervention in patients with pancreatic necrosis.
Methods: A total of 31 consecutive patients (18 male, median age 58 yrs.) diagnosed with pancreatic necrosis by
endoscopic ultrasound, in whom a decision for initial conservative treatment was made, were followed for the
need of interventions such as endoscopic or surgical intervention, or death.
Results: After a median follow-up of 243 days, 21 patients remained well without intervention and in 10 patients
an endpoint event occurred. In a multivariate logistic regression analysis of the clinical and endosonographic
parameters, liquid content was the single independent predictor for intervention (p = 0.0006). The presence of high
liquid content in the pancreatic necrosis resulted in a 64% predicted endpoint risk as compared to 2% for solid
necrosis.
Conclusions: Pancreatic necrotic cavities with high liquid content are associated with a high risk of complications.
Therefore, close clinical monitoring is needed and early elective intervention might be considered in these patients.Background
Pancreatic necrosis is a complication of both acute and
chronic pancreatitis. Its clinical presentation can range
from severe, life-threatening sepsis to oligosymptomatic
or even asymptomatic patients. Septic patients with
infected pancreatic necrosis on one end of the clinical
spectrum of severity are critically ill and require immedi-
ate treatment. The range of interventional treatment mo-
dalities in these patients includes surgery [1], transgastric
endoscopic drainage combined with necrosectomy [2,3],
placement of percutaneous drainages and irrigation [4]
or combinations of the above modalities. Recent evidence
suggests that minimal invasive or endoscopic approaches
are superior to open surgery [5-7]. However, even
infected necrosis can be managed conservatively in a
proportion of patients [8]. Thus, even in this life-threa-
tening condition, the selection of an appropriate treat-
ment modality is an as yet unsolved problem [9].* Correspondence: Christian.Juergensen@charite.de
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distribution, and reproduction in any mediumGiven the increased awareness and the improved im-
aging options of the pancreas such as endoscopic ultra-
sound, computed tomography and magnetic resonance
imaging, more oligosymptomatic or asymptomatic pan-
creatic lesions including necroses are being identified
and represent an additional challenge regarding their ad-
equate management strategy. In contrast to infected
necroses, the majority of these patients may be managed
conservatively as suggested by recent guidelines [10,11].
However, the technical advances of endoscopic and min-
imally invasive treatment modalities may lower the
threshold of intervention in this patient group. In choos-
ing an interventional strategy, the procedural risk has to
be weighed against the likely natural course of the pan-
creatic necrosis. Data regarding the procedural risk of
endoscopic necrosectomy and the recurrence rate in
non-infected patients are scarce. Seifert et al. reported a
26% complication rate and a 7.5% mortality rate in 93
patients for endoscopic necrosectomy [7]. This series
included 54% infected necroses – therefore, a significant
proportion of this morbidity and mortality may be
related to the active infection at the time of intervention.
On the other hand, persistent or secondary infection oftral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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of particular concern because potentially delayed treat-
ment may lead to intractable sepsis with resultant mor-
tality. The proportion of non-infected necroses that
progress to infection depends on the clinical context. In
acute pancreatitis necroses are most likely to become
infected three to four weeks after the onset of acute pan-
creatitis [12]. In contrast to studies on acute treatment,
data on secondary infection rates after this time frame
are rare. Rau et al. reported a mortality rate of 6.2% in
non-surgically treated patients with sterile necrosis [13].
The knowledge of factors predicting long-term success
of conservative treatment would be critical to make a
risk adjusted initial management decision for a newly
diagnosed pancreatic necrosis. This study therefore
sought to define morphologic endoscopic ultrasound cri-
teria for the prognosis and need of intervention in a




All consecutive patients meeting the inclusion criteria
listed below were included from January 2007 to June
2009 at the regional hospital Chemnitz and from July
2009 to June 2010 at the university hospital Schleswig-
Holstein in Kiel. The following criteria were required: i)
a diagnosis of pancreatic necrosis based on EUS morph-
ology and ii) an initial decision for conservative manage-
ment during the hospital stay or at presentation, when
seen as outpatient. All patients had a history of acute
and/or chronic pancreatitis.
The presence of pancreatic necrosis was defined on
the basis of EUS morphology as utilized previously in
the literature [14,15]. The morphological criterion for
necrosis itself was the presence of solid material with
increased or mixed echogenicity. The differential diagno-
sis to localized pancreatitis was based on the presence of
preserved tissue and ductal structures and vascular-
ization, which are both present in the latter case. The
morphological differential diagnosis to pancreatic carcin-
oma was also made on the basis of vascularization,
ductal anatomy and the presence of tissue invasion and
metastases. Importantly, adenocarcinomas would have
presented with a completely different clinical course
during the long term follow up of this study. In cases of
doubt, EUS fine needle aspiration was performed. When
compared with solely solid necrosis, those with add-
itional fluid were identified as structured hyperechogenic
material surrounded by fluid and without evidence of
blood flow on color Doppler and demarcation by a
hypoechogenic wall corresponding to circumferential fi-
brotic tissue. The EUS diagnosis of pancreatic necrosis
was supported by consistent clinical data, EUS-guidedfine needle aspiration and/or other imaging modalities
(such as computed tomography) if needed.
Patients in severe pain, with conservatively uncontrol-
lable infection, or with symptomatic gastroduodenal
compression leading to inability of oral food intake
underwent interventions and were not included in this
study. Elevated infection parameters such as C-reactive
protein levels were tolerated (and recorded) at discharge,
if the clinical and laboratory course indicated a progres-
sive recovery without intervention. Four patients were
seen as outpatients. The in-hospital treatment of 27
patients consisted of antibiotics in case of suspected in-
fection, enteral nutrition as soon as possible, and dis-
charge without any intervention. Patients were informed
to contact either their physician or hospital in case of
fever, pain, or other abdominal symptoms. Patients’
demographics such as age, gender, presenting symptoms
and comorbidities were recorded. Primary endpoints
were death or the need for intervention related to the
pancreatic necrosis such as pancreatic surgery, percutan-
eous drainage, or endoscopic treatment of necrosis. All
patients were followed prospectively by telephone calls
for primary endpoints or for other details related to pan-
creas or pancreatic necrosis.
Scoring of EUS morphology
Location and size of the necrotic cavity were documen-
ted by EUS. The EUS-morphology of pancreatic necrosis
at presentation was classified according to the following
parameters: i) proportion of solid material (0: completely
solid; 1: predominantly solid (>50% of solid material in
the cavity) and 2: predominantly fluid) and ii) echogeni-
city of fluid if present (0: echo-free vs. 1: with increased
echogenicity). Figure 1 shows some examples of scoring
for liquid content and echogenicity of the pancreatic
necrotic cavity.
EUS examination
EUS examinations were performed by usage of flexible
ultrasound video-endoscopes (Pentax EG 3630UR, EG-
3870UTK (Pentax Europe GmbH, Hamburg, Germany)
or GF-UCT160-AT8 (Olympus Deutschland GmbH,
Hamburg, Germany).
Statistical analysis
Statistical analysis was performed using SPSS version
18.0 (IBM Corp, Somers, NY 10589, USA) and R
(www.r-project.org). Logistic regression with step-wise
forward inclusion of variables was performed with
SPSS, logistic regression and linear regression with R
used the glm() and lm() functions. The function glm()
is the standard implementation in R to fit generalized
linear models and is used with the “binomial” argu-
ment to fit logistic regression models [16,17]. Similarly
Figure 1 EUS morphology of pancreatic necrosis. The figure provides examples of the types of necrosis and the scoring of liquid content and
echogenicity as utilized in Table 1 and the analysis. Panel A: Solid pancreatic necrosis (scored as 0 for liquid content and 0 for echogenicity,
patient #22 in Table 1); Panel B: Predominantly solid necrosis with echo-free liquid (scored as 1/0 for liquid and echogenicity, patient #2), Panel C:
predominantly liquid necrosis with echogenic fluid (scored as 2/1, patient #27) with a diameter of 49 millimeters; Panel D: predominantly liquid
necrosis with echo-free fluid in the cavity (scored as 2/0 for liquid and echogenicity, patient #1).
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no review committee was consulted.
Results
Thirty-one patients (58% male, median age 58 years)
were followed prospectively after the initial decision for
conservative treatment for a median of 243 days (range
60 – 922 days). During follow-up, 21 of these patients
(68%) remained well without any pancreatic interven-
tions; 20 patients remained symptom-free and one pa-
tient reported minor discomfort. Ten patients reached
the study endpoint, either requiring intervention or suf-
fering complications of their pancreatic necrosis. Of
these, three patients underwent endoscopic necrosect-
omy, two percutaneous and one endoscopic drainage of
their infected pancreatic necrosis, one patient with
advanced lung cancer died from sepsis not influenced by
endoscopic drainage, one other died from ileus before
surgery could be performed, and two had open surgery
(one for pancreatic necrosis and one for carcinoma of
the pancreatic head). The latter had not been diagnosed
16 months earlier when presenting with focal necrotiz-
ing pancreatitis within the pancreatic tail not accompan-
ied by any pancreatic duct dilation. An overview of all
patient characteristics and outcomes is given in Table 1.
Upon variable analysis of predictors of patient out-
come (i.e. reaching the endpoint), both liquid score(deviance based χ2 statistic, pD = 5.75 × 10
-4) and the
diameter of the necrosis (pD = 6.68 × 10
-4) were signifi-
cantly associated with outcome. None of the other clin-
ical or demographic parameters such as age, gender,
level of C-reactive protein (CRP), pain upon presenta-
tion, echogenicity and air content were associated with
reaching the endpoint. For seven patients, CRP levels
were not available for analysis. The missing values were
distributed between the endpoint groups similarly to the
overall cohort (five missing in patients without an end-
point score and two in patients that reached the end-
point). The available data do not suggest an impact of
CRP on outcome (pD = 0.81). The descriptive statistics
and single point p-values are provided in Table 2.
The two significant predictors in the single variable
analysis, namely the liquid score and the diameter of
necrosis were correlated. Figure 2 shows the correl-
ation of the liquid score and the diameter of the pan-
creatic necrotic cavity as scatterplot and the fitted
linear model line (r2 = 0.55, F-statistic p = 1.59 × 10-6).
In order to define the single most relevant parameter
for the prediction of outcome, multiple logistic regres-
sion analysis using all potential predictor variables in
forward likelihood based inclusion was performed.
Here, the liquid score was identified as the single inde-
pendent predictor (Wald statistic p = 0.009, deviance
based statistic pD = 5.75 × 10
-4). Models constructed by
inclusion of the liquid score (deviance statistic
D = 5.75 × 10
-4), the diameter of necrosis (pD = 0.16) and
an interaction term (pD = 0.99) confirmed these results.
In fact, none of the ten patients without documented
fluid within their pancreatic necrosis on EUS needed any
Table 1 Characteristics and endpoints of all 31 patients
with inclusion criteria: pancreatic necrosis as diagnosed
by EUS+ initial conservative treatment
Characteristics at presentation:
• Age: median 58 years [range 21 - 82]
• Gender: male (n = 18); female (n = 13)
• Pain in 2 patients (6%)
• C-reactive peptide (CRP): median 12 mg/l [range <0,4 – 107]
(not available in 7 patients)
• Diameter of necrosis: median 44 mm [range 16 - 110]
• Echogenicity of fluid: increased in 17 patients (54%)
• Air bubbles in necrotic cavity: 1 patient (3%)
• Interval to acute pancreatitis or acute attack of chronic pancreatitis:
median 119 d [19 – 1460] (not available in 17 patients with chronic
pancreatitis or incidental finding of necrosis)
Follow up: Median 243 days [60 – 922]
Outcome:
• without primary endpoint (n = 21)
• with primary endpoints (n = 10)
o Necrosectomy (n = 4)
3 x endoscopic necrosectomy, 1x open surgery
o Other surgery (n = 1): pancreatic head carcinoma
o Drainage (n = 4)
2 x percutaneous drainage; 2 x endosopic drainage (including one
patient dying from sepsis)
o Other death (n = 1): ileus
Figure 2 Liquid score and diameter. The correlation of the liquid
score and diameter of the necrosis is shown in this scatter-plot. The
line corresponds to the fitted linear model (F-statistic, p-value:
1.59 × 10-6).
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60–548). On the basis of the logistic regression model,
the risk for reaching the endpoint in patients with solid
necrosis was estimated at 3%. In contrast, patients with
liquid scores of one (low amounts of liquid present) and
two (predominantly liquid content) were estimated 18%
and 64%, respectively in the logistic regression model.






Age (median years) 62.5
Gender (% male) 40%
CRP (median mg/dl) 8
Presence of pain (%) 10%
Liquid score
(with score: 0/1/2)










CRP, C-reactive peptide.were very similar, namely 62% (8 out of 13) for liquid
necrosis, 25% (2 out of 8) for necrosis with low amounts
of liquid and 0% (10 out of 10) for solid necrosis.Discussion
The armamentarium for interventional and surgical
treatment of pancreatic necrosis and cysts has expanded
significantly over the last years [2,4-7]. Although the
technical feasibility regarding endoscopic necrosectomy
is established and the training level of endoscopists is in-
creasing, a clear definition of indications for intervention
is still needed, because a significant proportion of












/28 %/24% 0.009 5.75 × 10-4
57 % 0.709 0.710
5% 0.994 0.373
37 0.007 6.68 × 10-4
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therapy of the pancreatic necrosis could transform an
elective procedure in a stable patient into a high risk
intervention in the setting of sepsis. Thus, this study
aimed to define EUS criteria to guide the threshold of
intervention in pancreatic necrosis that does not require
immediate intervention because of sepsis, gastric ob-
struction or other complications.
In this study, the single most relevant predictor for
the need of intervention proved to be the liquid con-
tent of the necrotic cavity. In the single predictor ana-
lysis, the size of the pancreatic necrosis was also
significantly associated with outcome, but proved to be
inferior to the liquid score on multivariate logistic re-
gression analysis. Both parameters were highly corre-
lated, which corresponds to the clinical reality – i.e.
large necrosis cavities tend to have a predominantly li-
quid content. Biologically, the presence of undrained
liquid may correlate with the chance of a secondary
infectious event, since the distance from the blood cir-
culation increases the difficulty to control bacteria by
the immune system as well as by systemically given
antibiotics while providing a medium for rapid spread
of infection through the fluid pool. Indeed, such an in-
fectious event led to intervention in 6 of our 10
patients with an endpoint event. Additionally, fluid
could be an indicator of chronic minimal leakage fed
by an injured pancreatic duct, leading to problems
such as pain or increasing size.
Interestingly, increased echogenicity of fluid was not
predictive for treatment necessity during follow up. This
corresponds to clinical experience in endoscopically
treated patients, that an increase of echogenicity is seen
both in putrid fluid as well as in clear dark fluid without
evidence of infection. Thus, the morphology of the ne-
crosis as defined by liquid content and diameter defines
the clinical course in the long term.
The initial decision for patients with EUS documented
pancreatic necrosis for conservative treatment is based
on lack of clinical indicators for immediate interven-
tions, i.e. pain, uncontrolled infection, inability of oral
nutrition, or suspicion for malignancy. In many
patients, the decision based on the presence of these in-
dicative symptoms is not clear-cut but based on a
spectrum of clinical variables and personal experience.
The non-randomized assignment of patients to conser-
vative treatment is a potential weakness of this study.
Being aware of this limitation, the long-term clinical fol-
low-up provides a hard clinical outcome measure of the
parameters obtained during the initial clinical evalu-
ation. We thus hope, that the morphological parameters
provided here, can help guide the therapeutic manage-
ment resulting in a judicious use of endoscopic necro-
sectomy in the future.Conclusions
Patients with necrotic pancreatic cavities of predomin-
antly liquid content should be monitored closely and
may be considered for earlier, elective interventional
treatment, because this patient group has a significant
risk for severe complications in their clinical course.
Conversely, solid necrosis may be relatively safely man-
aged conservatively. Further, preferably randomized
studies on this subject are needed.
Additional file
Additional file 1: Table S1. STROBE Statement
Competing interests
The authors declare that they have no competing interests.
Acknowledgements
Thanks to V. Loening-Baucke for her valuable comments and to M.
Kirchberger for her help by collecting data for this study.
Author details
1Department of Gastroenterology, Charité University Campus Mitte, Berlin,
Germany. 2Interdisciplinary Endoscopy, Department of Medicine I, University
Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany. 3Department of
Medicine II, Klinikum Chemnitz, Chemnitz, Germany.
Authors' contributions
CJ, AF and JH participated in conception and design of the study. CJ, AA,
and JH participated in drafting of the article. All authors were involved in
analysis and interpretation of the study and in provision of study patients. All
authors read and approved the final manuscript.
Received: 7 August 2011 Accepted: 14 May 2012
Published: 14 May 2012
References
1. Nieuwenhuijs VB, Besselink MG, van Minnen LP, Gooszen HG: Surgical
management of acute necrotizing pancreatitis: a 13-year experience
and a systematic review. Scand J Gastroenterol Suppl 2003, 38(Suppl
239):111–116.
2. Seifert H, Wehrmann T, Schmitt T, Zeuzem S, Caspary WF: Retroperitoneal
endoscopic debridement for infected peripancreatic necrosis. Lancet
2000, 356:653–655.
3. Schrover IM, Weusten BL, Besselink MG, Bollen TL, van Ramshorst B, Timmer
R: EUS-guided endoscopic transgastric necrosectomy in patients with
infected necrosis in acute pancreatitis. Pancreatology 2008, 8:271–276.
4. Becker V, Huber W, Meining A, Prinz C, Umgelter A, Ludwig L, Bajbouj M,
Gaa J, Schmid RM: Infected necrosis in severe pancreatitis–combined
nonsurgical multi-drainage with directed transabdominal high-volume
lavage in critically ill patients. Pancreatology 2009, 9:280–286.
5. van Santvoort HC, Besselink MG, Bakker OJ, Hofker HS, Boermeester MA,
Dejong CH, van Goor H, Schaapherder AF, van Eijck CH, Bollen TL, van
Ramshorst B, Nieuwenhuijs VB, Timmer R, Laméris JS, Kruyt PM, Manusama
ER, van der Harst E, van der Schelling GP, Karsten T, Hesselink EJ, van
Laarhoven CJ, Rosman C, Bosscha K, de Wit RJ, Houdijk AP, van Leeuwen
MS, Buskens E, Gooszen HG, Dutch Pancreatitis Study Group: A step-up
approach or open necrosectomy for necrotizing pancreatitis. N Engl J
Med 2010, 362:1491–1502.
6. Besselink MG, de Bruijn MT, Rutten JP, Boermeester MA, Hofker HS, Gooszen
HG: Dutch Acute Pancreatitis Study Group. Surgical intervention in
patients with necrotizing pancreatitis. Br J Surg 2006, 93:593–599.
7. Seifert H, Biermer M, Schmitt W, Jürgensen C, Will U, Gerlach R, Kreitmair C,
Meining A, Wehrmann T, Rösch T: Transluminal endoscopic necrosectomy
after acute pancreatitis: a multicentre study with long-term follow-up
(the GEPARD Study). Gut 2009, 58:1260–1266.
Jürgensen et al. BMC Gastroenterology 2012, 12:48 Page 6 of 6
http://www.biomedcentral.com/1471-230X/12/488. Runzi M, Niebel W, Goebell H, Gerken G, Layer P: Severe acute pancreatitis:
nonsurgical treatment of infected necroses. Pancreas 2005, 30:195–199.
9. van Santvoort HC, Besselink MG, Bakker OJ, Vleggaar FP, Timmer R, Weusten
BL: Gooszen HG; Dutch Pancreatitis Study Group. Endoscopic necrosectomy
in necrotising pancreatitis: indication is the key. Gut 2010, 59:1587.
10. Working Party of the British Society of Gastroenterology; Association of
Surgeons of Great Britain and Ireland, Pancreatic Society of Great Britain
and Ireland, Association of Upper GI Surgeons of Great Britain and
Ireland: UK guidelines for the management of acute pancreatitis. Gut
2005, 54(Suppl 3):iii1–iii9.
11. Forsmark CE, Baillie J: AGA Institute technical review on acute
pancreatitis. Gastroenterology 2007, 132:2022–2044.
12. Uhl W, Warshaw A, Imrie C: McKay CJ, Lankisch PG, Carter R, Di Magno E,
Banks PA, Whitcomb DC, Dervenis C, Ulrich CD, Satake K, Ghaneh P,
Hartwig W, Werner J, McEntee G, Neoptolemos JP, Büchler MW;
International Association of Pancreatology. IAP Guidelines for the Surgical
Management of Acute Pancreatitis. Pancreatology 2002, 2:565–573.
13. Rau B, Pralle U, Uhl W, Schoenberg MH, Beger HG: Management of sterile
necrosis in instances of severe acute pancreatitis. J Am Coll Surg 1995,
181:279–288.
14. Charnley RM, Lochan R, Gray H, O'Sullivan CB, Scott J, Oppong KE:
Endoscopic necrosectomy as primary therapy in the management of
infected pancreatic necrosis. Endoscopy 2006, 38:925–928.
15. Voermans RP, Veldkamp MC, Rauws EA, Bruno MJ, Fockens P: Endoscopic
transmural debridement of symptomatic organized pancreatic necrosis
(with videos). Gastrointest Endosc 2007, 66:909–916.
16. McCullagh P, Nelder JA: Generalized Linear Models. Chapman and Hall:
London; 1989.
17. Venables WN, Ripley BD: Modern Applied Statistics with S. Springer: New
York; 2002.
18. Development Core Team R: R: A language and environment for statistical
computing. Vienna, Austria: R Foundation for Statistical Computing; 2008.
2008.
doi:10.1186/1471-230X-12-48
Cite this article as: Jürgensen et al.: Endoscopic ultrasound criteria to
predict the need for intervention in pancreatic necrosis. BMC
Gastroenterology 2012 12:48.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
